As far as we know, the patent has been filed in th

As far as we know, the patent has been filed in the US only and we know that the Company has pursued international protection for previous patents. Given the broad reach of this new technology, I would assume the same strategy with this patent.

With this assumption in mind, I spent a little time pondering the mechanics of how a licensing deal would be done. The Company obviously wouldn't want to share the specifics of the technology, at least without strict confidentiality agreements in place.

This leads me to think that 'demonstrated interest' implies confidentiality agreements have been signed or at least is in the process of being signed. Even so, I wonder how an interested party would reach satisfaction in the claims of the technology. I figure at a minimum 1) understanding the tech and 2) trying it out on their own in the lab and proofing it against existing methods. These should be enough to move any deal forward and final execution contingent on successful clinical trials, which should go quickly (and would be necessary for FDA approval).

What did the CEO say? It took 40 days to go from concept to confirmation in the lab? I would expect a repeat for demonstration to a potential licensee would take half that time, possibly even less. From a super optimistic perspective, maybe we hear of agreement(s) in 2-3 weeks from today.